Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Abstract Text:

Staci M Lockhart,Michelle R Salvaggio,Michael S Bronze,Ronald A Greenfield,Staci M Lockhart,Michelle R Salvaggio,Michael S Bronze,Ronald A Greenfield,

The incidences of viral infectious diseases are increasing at an alarming rate in the US and worldwide. Antiviral therapy is challenging because viruses subsume normal host cellular mechanisms for many functions, have rapid replication rates, have poor error scanning when reading genetic code, and undergo frequent drug target mutations. This article will focus on antiviral drugs and principles of treatment for infections due to herpes simplex viruses (HSV1 and HSV2), varicella zoster virus (VZV), cytomegalovirus (CMV), hepatitis B and hepatitis C viruses, and influenza virus. Therapy for human immunodeficiency virus (HIV) infection will be discussed in the next symposium segment.

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Publishing Authors By Initials

SM Lockhart,MR Salvaggio,MS Bronze,RA Greenfield,SM Lockhart,MR Salvaggio,MS Bronze,RA Greenfield,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of the Oklahoma State Medical Associat

VOLUME: 100

Page Numbers: 388-95

Journal Abbreviation:

ISSN: 0030-1876

DAY: 18

MONTH: Oct

YEAR: 2007

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7503043

Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.

AFFILIATION: College of Pharmacy Building, Oklahoma City, OK 73117, USA. Staci-Lockhart@ouhsc.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Okla State Med Assoc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Part XIV Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza Related Publications

• 'DNA' may not mean 'did not participate': a qualitative study of reasons for non-adherence at home- and centre-based cardiac rehabilitation.
• A comparative multi-level analysis of contextual drinking in American and Canadian adults.
• A comparison of structural measurements using 2 Stratus optical coherence tomography instruments.
• A foetal plethysmograph.
• A method for measuring the blood flow in the umbilical vessels.
• A multifaceted approach to neuroscience outreach: meeting the challenges.
• Aging and surgeon performance.
• Book reviews.
• Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening.
• Concurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE study.
• Determination of the folding of proteins as a function of denaturants, osmolytes or ligands using circular dichroism.
• Differential dynamics of transient neuronal assemblies in visual compared to auditory cortex.
• Evaluating quality improvement.
• Factor analysis of the Alcohol and Drug Confrontation Scale (ADCS).
• Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
• Inhibition of the PI3K-Akt signaling pathway reduces tumor necrosis factor-alpha production in response to titanium particles in vitro.
• Making another world possible: the Torah, Louis Kelso, and the problem of poverty.
• Molecular basis of tropomyosin binding to tropomodulin, an actin-capping protein.
• Next generation of self-management education: Web-based bipolar disorder program.
• Olivoponto-cerebellar atrophy.
• Part XIII. Systemic antifungal therapy.
• Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
• Recent advances in analytical spectroscopy by K. Fuwa. Pergamon Press, Oxford, 1982, pp. 325, ISBN 0-08-026221 1X, pound42.00.
• Reflections on leukemia and adult stem-cell transplantation: some personal psychological factors.
• Relaxation time, diffusion, and viscosity analysis of model asphalt systems using molecular simulation.
• Scanning laser polarimetry with enhanced corneal compensation and optical coherence tomography in normal and glaucomatous eyes.
• Sexually dimorphic expression of secreted frizzled-related (SFRP) genes in the developing mouse Müllerian duct.
• The balance between endotoxin accumulation and clearance during particle-induced osteolysis in murine calvaria.
• The relationship of self-esteem and self-efficacy to treatment outcomes of alcohol-dependent men and women.
• Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions.